These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1519536)

  • 21. Achieving optimal lipid goals in patients with coronary artery disease.
    Karalis DG; Subramanya RD; Hessen SE; Liu L; Victor MF
    Am J Cardiol; 2011 Mar; 107(6):886-90. PubMed ID: 21247526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Total cholesterol, low density lipoprotein cholesterol, and high density lipoprotein cholesterol and coronary heart disease in Scotland.
    Hargreaves AD; Logan RL; Thomson M; Elton RA; Oliver MF; Riemersma RA
    BMJ; 1991 Sep; 303(6804):678-81. PubMed ID: 1912914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of cholesterol levels and ratios in predicting future coronary heart disease in a Chinese population.
    Wang TD; Chen WJ; Chien KL; Seh-Yi Su SS; Hsu HC; Chen MF; Liau CS; Lee YT
    Am J Cardiol; 2001 Oct; 88(7):737-43. PubMed ID: 11589839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identifying patients at risk for coronary heart disease: implications from trials of lipid-lowering drug therapy.
    Isles CG; Paterson JR
    QJM; 2000 Sep; 93(9):567-74. PubMed ID: 10984551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Should we measure lipoprotein Lp(a)?
    Wilson PW; Kannel WB
    Arch Intern Med; 1997 Jun; 157(11):1161-2. PubMed ID: 9183225
    [No Abstract]   [Full Text] [Related]  

  • 26. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).
    Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
    JAMA; 2001 May; 285(19):2486-97. PubMed ID: 11368702
    [No Abstract]   [Full Text] [Related]  

  • 27. [Comparison of 2 electrophoretic procedures for quantifying lipoprotein cholesterol].
    Kessler B; Aufenanger J; Kattermann R
    Klin Wochenschr; 1990; 68 Suppl 22():110-1. PubMed ID: 2087065
    [No Abstract]   [Full Text] [Related]  

  • 28. Rationale for use of non-high-density lipoprotein cholesterol rather than low-density lipoprotein cholesterol as a tool for lipoprotein cholesterol screening and assessment of risk and therapy.
    Frost PH; Havel RJ
    Am J Cardiol; 1998 Feb; 81(4A):26B-31B. PubMed ID: 9526810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improving the prediction of cardiovascular risk: interaction between LDL and HDL cholesterol.
    Grover SA; Dorais M; Coupal L
    Epidemiology; 2003 May; 14(3):315-20. PubMed ID: 12859032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of the patient with a low HDL-cholesterol.
    Leighton RF
    Clin Cardiol; 1990 Aug; 13(8):521-32. PubMed ID: 2204505
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.
    Evans M; Roberts A; Davies S; Rees A
    Drugs; 2004; 64(11):1181-96. PubMed ID: 15161326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LDL-cholesterol versus non-HDL-to-HDL-cholesterol ratio and risk for coronary heart disease in type 2 diabetes.
    Eliasson B; Gudbjörnsdottir S; Zethelius B; Eeg-Olofsson K; Cederholm J;
    Eur J Prev Cardiol; 2014 Nov; 21(11):1420-8. PubMed ID: 23774274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HDL-cholesterol as a risk factor in coronary heart disease. An update of the Helsinki Heart Study.
    Frick MH; Manninen V; Huttunen JK; Heinonen OP; Tenkanen L; Mänttäri M
    Drugs; 1990; 40 Suppl 1():7-12. PubMed ID: 2289410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Residual dyslipidemia among United States adults treated with lipid modifying therapy (data from National Health and Nutrition Examination Survey 2009-2010).
    Wong ND; Chuang J; Wong K; Pham A; Neff D; Marrett E
    Am J Cardiol; 2013 Aug; 112(3):373-9. PubMed ID: 23642513
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).
    Goldenberg I; Benderly M; Sidi R; Boyko V; Tenenbaum A; Tanne D; Behar S
    Am J Cardiol; 2009 Jan; 103(1):41-5. PubMed ID: 19101227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol.
    Bersot TP; Pépin GM; Mahley RW
    Am Heart J; 2003 Dec; 146(6):1052-9. PubMed ID: 14660998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-density lipoprotein, low-density lipoprotein and coronary artery disease.
    Wilson PW
    Am J Cardiol; 1990 Sep; 66(6):7A-10A. PubMed ID: 2203248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increasing high-density lipoprotein cholesterol: an update on fenofibrate.
    Després JP
    Am J Cardiol; 2001 Dec; 88(12A):30N-36N. PubMed ID: 11788128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-density vs low-density lipoprotein cholesterol as the risk factor for coronary artery disease and stroke in old age.
    Weverling-Rijnsburger AW; Jonkers IJ; van Exel E; Gussekloo J; Westendorp RG
    Arch Intern Med; 2003 Jul; 163(13):1549-54. PubMed ID: 12860577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive value for coronary heart disease of baseline high-density and low-density lipoprotein cholesterol among Fredrickson type IIa subjects in the Helsinki Heart Study.
    Manninen V; Koskinen P; Manttari M; Huttunen JK; Canter D; Frick HM
    Am J Cardiol; 1990 Sep; 66(6):24A-27A. PubMed ID: 2392990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.